Jason Westin/LinkedIn
May 31, 2025, 14:16
Jason Westin: CAR T-Cell Therapy Offers Best Chance for Long-Term Remission in Advanced Cancers
Jason Westin, Professor, Director of Lymphoma Clinical Research and Section Chief of Aggressive Lymphoma at MD Anderson Cancer Centre, shared a post on LinkedIn:
“CAR T-cell therapy offers the best chance for long-term remission — and perhaps cure — for patients with some advanced cancers. But here’s the reality: only 2 in 10 eligible patients in the U.S. receive it. That must change.
Today, CAR T Vision launches with an ambitious but achievable goal: double access to CAR T-cell therapy by 2030. We’re building a movement to make our vision real — for patients, caregivers, clinicians, and advocates.
It will take all of us working together.
Read the new roadmap report and see how you can be part of the coalition.”
You Can Also Read CAR T Cell Therapy for Cancer Treatment by OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 3, 2025, 10:25
Jul 3, 2025, 10:24
Jul 3, 2025, 10:16
Jul 3, 2025, 10:15
Jul 3, 2025, 10:04
Jul 3, 2025, 09:50